Investor Relations
The investor pages that follow are your resource for financial information about Achillion Pharmaceuticals. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.
May 18, 2012
Achillion Announces Executive Promotion
May 15, 2012
ACH-3102 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C
|